Диссертация (1150004), страница 17
Текст из файла (страница 17)
To protect peptide pharmaceuticalsagainst peptidases // J. Pharmacol. Toxicol. Methods. – 2010. – Vol. 61. – № 2. – P.210–218.38. Itakura, K.; Hirose, T.; Crea, R. Expression in Escherichia coli of a chemicallysynthesized gene for the hormone somatostatin // Science. – 1977. – Vol. 198. – №4321. – P. 1056–1063.39. Crea, R.; Kraszewski, A.; Hirose, T.; Itakura, K. Chemical synthesis of genes forhuman insulin // Proc. Natl Acad.
Sci. USA. – 1978. – Vol. 75. – № 12. – P. 5765–5769.40. Goeddel, D. V; Kleid, D. G.; Bolivar, F. Expression in Escherichia coli ofchemically synthesized genes for human insulin // Proc. Natl Acad. Sci. USA. –1979. – Vol. 76. – № 1. – P. 106–110.41. du Vigneaud, V.; Ressler, C.; Swan, J. M.; Katsoyannis, P. G.; Roberts, C. W.The synthesis of an octapeptide amide with the hormonal acitivity of oxytocin // J.Am. Chem. Soc. – 1953. – Vol.
75. – № 19. – P. 4879–4880.42. Merrifield, R. B. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide// J. Am. Chem. Soc. – 1963. – Vol. 85. – № 14. – P. 2149–2154.43. Andersson, L.; Blomberg, L.; Flegel, M.; Lepsa, L.; Nilsson, B.; Verlander, M.Large-Scale Synthesis of Peptides // Biopolymers. – 2000. – Vol. 55. – № 3. – P.227–250.44. Chan, W.C.; White, P. D.; Fmoc solid phase peptide synthesis, Oxford UniversityPress, Oxford, UK, 2004.45. Rink, H. Solid-phase synthesis of protected peptide fragments using a trialkoxydiphenyl-methylester resin // Tetrahedron Letters.
– 1987 – Vo1. 28. – №33. – P.3787-3790.11046. Roberts, C. R.; Chen, L.; Han, Y.-K. “Insulinotropic peptide synthesis using solidand solution phase combination techniques.”United States 20110213082. Sept.2011.47. Marx, V. Roche’s Fuzeon challenge // Chem. Eng. News. – 2005. – Vol. 83. – №11.
– P. 16–17.48. Amblard, M.; Fehrentz, J. A.; Martinez, J.; Subra, G. Methods and protocols ofmodern solid phase peptide synthesis // Mol. Biotechnol – 2006. – Vol. 33. – № 3. –P. 239–254.49. Guzman, F.; Barberis, S.; Illanes, A. Peptide synthesis: chemical or enzymatic //J. Biotechnol. – 2007. – Vol. 10. – P. 279–314.50. Dawson, P. E.; Muir, T. W.; Clark-Lewis, I.; Kent, S. B. Synthesis of proteins bynative chemical ligation // Science. – 1994. – Vol.
266. – № 5186. – P. 776–779.51. Torreira, E.; Schoehn, G.; Fernández, Y.; Jorba, N.; Ruigrok, R. W.; Cusack, S.;Ortín, J.; Llorca, O. Three-dimensional model for the isolated recombinant influenzavirus polymerase heterotrimer // Nucleic Acids Res. – 2007. – Vol. 35. – № 11.
– P.3774–3783.52. Hörner, M.; Weber, W. Molecular switches in animal cells // FEBS Letters. –2012. – Vol. 586. – № 15. – P. 2084–2096.53. Fernando, A.; Hendrik, G. K. Therapeutic peptides // Future MedicinalChemistry. – 2012. – Vol. 4 . – № 2. – P. 1527–1531.54. Shijun, Z.; Alba, T. M.; MacKerell Jr., A.D. Computational Identification ofInhibitors of Protein-Protein Interactions // Current Topics in Medicinal Chemistry. –2007. – Vol. 7. – P. 63–82.55. Smith, M.C.; Gestwicki, J.
E. Features of protein-protein interactions thattranslate into potent inhibitors – topology, surface area and affinity // Expert Reviewsin Molecular Medicine. – 2012. – Vol. 14. – P. e16.56. Pal, A.; Chakrabarti, P.; Bahadur, R.; Rodier, F.; Janin, J. Peptide segments inprotein-protein interfaces // Journal of Biosciences. – 2006. – Vol. 32. – № 1. – P.101–111.11157.
Chen, L.; Hahn, H.; Wu, G.; Chen, C. H.; Liron, T.; Schechtman D.; Cavallaro,G.; Banci, L.; Guo, Y.; Bolli, R.; Dorn II, G. W.; Mochly-Rosen, D. Opposingcardioprotective actions and parallel hypertrophic effects of δPKC and ɛPKC //Proceedings of the National Academy of Sciences. – 2001. – Vol. 98. – № 20. – P.11114–11119.58. Ron, D.; Mochly-Rosen, D. An autoregulatory region in protein kinase C – thepseudoanchoring site // Proceedings of the National Academy of Sciences. – 1995. –Vol. 92.
– № 2. – P. 492–496.59. Skrabanek, L.; Saini, H. K.; Bader, G. D.; Enright, A. J. Computational predictionof protein-protein interactions // Molecular Biotechnology. – 2008. – Vol. 38. – № 1.– P. 1–17.60. Rutkowska, A.; Schultz, C. Protein tango – the toolbox to capture interactingpartners // Angewandte Chemie International Edition. – 2012. – Vol. 51. – № 33. – P.8166-8176.61. Völkel, P.; le Faou, P.; Angrand, P. O. Interaction proteomics – characterizationof protein complexes using tandem affinity purification-mass spectrometry //Biochemical Society Transactions.
– 2010. – Vol. 38. – P. 883–887.62. Parrish, J. R.; Gulyas, K. D.; Finley Jr., R. L. Yeast two-hybrid contributions tointeractome mapping // Current Opinion in Biotechnology. – 2006. – Vol. 17. – № 4.– P. 387–393.63. Liu, Z.; Chen, L. Proteome-wide prediction of protein-protein interactions fromhigh-throughput data // Protein & Cell. – 2012. – Vol. 3. – № 7. – P. 508–520.64. Cusick, M.
E.; Klitgord, N.; Vidal, M.; Hill, D. E//HumanMolecularGenetics. – 2005. – Vol. 14. – № 2. – P. R171–181.65. Qvit, N.; Mochly-Rosen, D. Highly specific modulators of protein kinase Clocalization – applications to heart failure // Drug Discovery Today: DiseaseMechanisms. – 2010. – Vol. 2. – P.
e87–e93.66. Souroujon, M. C.; Mochly-Rosen, D. Peptide modulators of protein–proteininteractions in intracellular signaling // Nature Biotechnology. – 1998. – Vol. 16. – №10. – P. 919–924.11267. Koch, W. J.; Inglese, J.; Stone, W.
C.; Lefkowitz, R. J. The binding site for thebeta gamma subunits of heterotrimeric G proteins on the beta-adrenergic receptorkinase // Journal of Biological Chemistry. – 1993. – Vol. 268. – № 11. – P. 8256–8260.68. Nevalainen, L. T.; Aoyama, T.; Ikura, M.; Crivici, A.; Yan, H.; Chua, N. H.;Nairn A. C. Characterization of novel calmodulin-binding peptides with distinctinhibitory effects on calmodulin-dependent enzymes // Biochemical Journal. – 1997.– Vol. 321. – Pt.
1. – P. 107–115.69. Ron, D.; Mochly-Rosen, D. Agonists and antagonists of protein kinase Cfunction, derived from its binding proteins // Journal of Biological Chemistry. – 1994.– Vol. 269. – № 34. – P. 21395-21398.70. Davey, N. E.; Edwards, R. J.; Shields D. C. Computational identification andanalysis of protein short linear motifs // Frontiers in Bioscience. – 2010. – Vol. 15. –P. 801–825.71. Neduva, V.; Russell, R.
B. Peptides mediating interaction networks: new leads atlast // Current Opinion in Biotechnology. – 2006. – Vol. 17. – № 5. – P. 465–471.72. Hernáez, B.; Tarragó, T.; Giralt, E.; Escribano, J. M.; Alonso, C. Small PeptideInhibitors Disrupt a High-Affinity Interaction between Cytoplasmic Dynein and aViral Cargo Protein // Journal of Virology. – 2010. – Vol. 84. – № 20. – P. 10792–10801.73. Jagger, B. W.; Wise, H. M.; Kash, J. C.; Walters, K.
A.; Wills, N. M.; Xiao, Y.L.; Dunfee, R. L. Overlapping protein-coding region in influenza A virus segment 3modulates the host response // Science. – 2012. – Vol. 337. – № 6091. – P. 199–204.74. Muramoto, Y.; Noda, T.; Kawakami, E.; Akkina, R.; Kawaoka, Y.Avirusproteins translated from PA mRNA // Journal of virology. – 2013. – Vol. 87.
– № 5. –P. 2455–2462.75. Wise, H. M.; Hutchinson, E. C.; Jagger, B. W.; Stuart, A. D.; Kang, Z. H.; Robb,N.; Schwartzman, L. M. Identification of a Novel Splice Variant Form of theInfluenza A Virus M2 Ion Channel with an Antigenically Distinct Ectodomain //PLoS Pathogen. – 2012. – Vol. 8. – № 11. – P. e1002998.11376. http://www.fda.gov77. Skehel, J. J.; Wiley, D. C. Receptor binding and membrane fusion in virus entry:the influenza hemagglutinin // Annu. Rev.
Biochem. – 2000. – Vol. 69. – P. 531–569.78. Harrison, S. C. Viral membrane fusion // Nat. Struct. Mol. Biol. – 2008. – Vol.15. – P. 690–698.79. Nobusawa, E.; Aoyama, T.; Kato, H.; Suzuki, Y.; Tateno, Y.; Nakajima, K.Comparison of complete amino acid sequences and receptor-binding propertiesamong 13 serotypes of hemagglutinins of influenza A viruses // Virology. – 1991.
–Vol. 182. – P. 475–485.80. Ha, Y.; Stevens, D. J.; Skehel, J. J.; Wiley, D. C. X-ray structures of H5 avian andH9 swine influenza virus hemagglutinins bound to avian and human receptor analogs// Proc. Natl. Acad. Sci. U. S. A. – 2001. – Vol. 98.
– P. 11181–11186.81. Gamblin, S. J.; Haire, L. F.; Russell, R. J.; Stevens, D. J.; Xiao, B.; Ha, Y.;Vasisht, N. The structure and receptor binding properties of the 1918 influenzahemagglutinin // Science. – 2004. – Vol. 303. – P. 1838–1842.82. Stevens, J.; Blixt, O.; Tumpey, T. M.; Taubenberger, J. K.; Paulson, J. C.;Wilson, I. A. Structure and receptor specificity of the hemagglutinin from an H5N1influenza virus // Science. – 2006. – Vol. 312. – P.
404–410.83. Yang, H.; Chen, L. M.; Carney, P. J.; Donis, R. O.; Stevens, J. Structures ofreceptor complexes of a North American H7N2 influenza hemagglutinin with a loopdeletion in the receptor binding site // PLoS Pathog. – 2010. – Vol. 6. – P. e1001081.84. Nandi, T. Proposed lead molecules against hemagglutinin of avian influenza virus(H5N1) // Bioinformation.
– 2008. – Vol. 2. – P. 240–244.85. Bodian, D. L.; Yamasaki, R. B.; Buswell, R. L.; Stearns, J. F.; White, J. M.;Kuntz, I. D. Inhibition of the fusion-inducing conformational change of influenzahemagglutinin by benzoquinones and hydroquinones // Biochemistry. – 1993. – Vol.32. – P. 2967–2978.86. Staschke, K.
A.; Hatch, S. D.; Tang, J. C.; Hornback, W. J.; Munroe, J. E.;Colacino, J. M.; Muesing, M. A. Inhibition of influenza virus hemagglutinin-114mediated membrane fusion by a compound related to podocarpic acid // Virology. –1998. – Vol. 248. – P. 264–274.87. Deshpande, M. S.; Wei, J.; Luo, G.; Cianci, C.; Danetz, S.; Torri, A.; Tiley, L. Anapproach to the identification of potent inhibitors of influenza virus fusion usingparallel synthesis methodology // Bioorg.
Med. Chem. Lett. – 2001. – Vol. 11. – P.2393–2396.88. Tang, G.; Qiu, Z.; Lin, X.; Li, W.; Zhu, L.; Li, S.; Li, H. Discovery of novel 1phenyl-cycloalkane carbamides as potent and selective influenza fusion inhibitors //Bioorg. Med. Chem. Lett. – 2010. – Vol. 20. – P. 3507–3510.89. Грипп: эпидемиология, диагностика, лечение, профилактика / под ред О.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
